OpenLB
Open Library of Bioscience

Takotsubo syndrome: The great imposter.

Abstract

No abstract text available.

References

1. Komamura K, Fukui M, Iwasaku T, Hirotani S, Masuyama T. Takotsubo cardiomyopathy: pathophysiology, diagnosis and treatment. World J Cardiol. 2014;6(7):602–609.
2. Tofield A. Hikaru Sato and Takotsubo cardiomyopathy. Eur Heart J. 2016;37(37):2812.
3. Tomich E. Takotsubo cardiomyopathy. Medscape/Emedicine. https://emedicine.medscape.com/article/1513631-overview.
4. Reeder G, Prasad A. Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy. UpToDate. www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-stress-takotsubo-cardiomyopathy?search=clinical%20manifestations%20and%20diagnosis%20of%20stress&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2.
5. Swenson S, Bull J, Chen IB, et al. Takotsubo cardiomyopathy: a discussion and case study. J Am Assoc Nurse Pract. 2018;30(7):392–397.
6. Tso M, Tam J, Khoo C. An atypical case of Takotsubo cardiomyopathy and transient global amnesia. Can J Cardiol. 2019;Open(1):35–38.
7. Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032–2046.
8. Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on Takotsubo syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(1):8–27.
9. Gopalakrishnan P, Zaidi R, Sardar MR. Takotsubo cardiomyopathy: pathophysiology and role of cardiac biomarkers in differential diagnosis. World J Cardiol. 2017;9(9):723–730.
10. Weiner MM, Asher DI, Augoustides JG, et al. Takotsubo cardiomyopathy: a clinical update for the cardiovascular anesthesiologist. J Cardiothorac Vasc Anesth. 2017;31(1): 334–344.
11. Scantlebury DC, Prasad A. Diagnosis of Takotsubo cardiomyopathy. Circ J. 2014;78(9):2129–2139.
12. Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): diagnostic workup, outcome, and management. Eur Heart J. 2018;39(22):2047–2062.
13. Altenberger J, Gustafsson F, Harjola V, et al. Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications. J Cardiovasc Pharmacol. (2018); 71(3): 129–136.
14. Reeder G, Prasad A. Management and prognosis of stress (takotsubo) cardiomyopathy. UpToDate. www.uptodate.com/contents/management-and-prognosis-of-stress-takotsubo-cardiomyopathy?search=takotsubo%20cardiomyopathy&source=search_result&selectedTitle=2~84&usage_type=default&display_rank=2.
15. Scally C, Rudd A, Mezincescu A, et al. Persistent long-term structural, functional, and metabolic changes after stress-induced (Takotsubo) cardiomyopathy. Circulation. 2018;137(10):1039–1048.

MeSH Term